{
    "clinical_study": {
        "@rank": "58654", 
        "arm_group": [
            {
                "arm_group_label": "Control Study Product", 
                "arm_group_type": "Placebo Comparator", 
                "description": "1 serving of control beverage."
            }, 
            {
                "arm_group_label": "Experimental Study Product", 
                "arm_group_type": "Experimental", 
                "description": "1 serving of a nutritional supplement for people with diabetes."
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this trial is to evaluate a nutritional supplement for people with\n      Diabetes."
        }, 
        "brief_title": "Evaluation of a Nutritional Supplement for People With Type 2 Diabetes.", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects will be eligible for the study if they meet all of the following inclusion\n             criteria:\n\n               1. Diagnosis of Type 2 Diabetes.\n\n               2. Age between 18 and 75 years.\n\n               3. HbA1c > 6.0 but \u2264 8.5\n\n               4. If female and of childbearing potential , subject is non-pregnant, non-\n                  lactating, at least 6 weeks postpartum and agrees to practice birth control\n                  throughout study duration.\n\n               5. BMI > 18.5 kg/m2 and < 40.0 kg/m2.\n\n               6. Chronic medication dosage must be stable for at least two months prior to\n                  Screening Visit.\n\n               7. Subject states that they are a habitual consumer of a morning meal.\n\n        Exclusion Criteria:\n\n          -  Subjects will be excluded from the study if they meet any of the following criteria:\n\n               1. Use of exogenous insulin or GLP-1 agonists for glucose control.\n\n               2. Diagnosis of Type 1 diabetes.\n\n               3. History of diabetic ketoacidosis.\n\n               4. Current infection (requiring medication or hospitalization), has received\n                  corticosteroid treatment in the last 3 months, or has had surgery or received\n                  antibiotics in the last 3 weeks.\n\n               5. Active malignancy.\n\n               6. Significant cardiovascular event < 12 weeks prior to study entry.\n\n               7. End stage organ failure or status post organ transplant.\n\n               8. Active metabolic, hepatic, or gastrointestinal disease.\n\n               9. Chronic, contagious, infectious disease.\n\n              10. Currently taking herbals, dietary supplements, or medications (other than\n                  antihyperglycemic medications) that could profoundly affect blood glucose.\n\n              11. History of fainting or other adverse reactions in response to blood collection.\n\n              12. Clotting or bleeding disorders.\n\n              13. Allergy or intolerance to study product ingredient."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "54", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01850134", 
            "org_study_id": "BL18"
        }, 
        "intervention": [
            {
                "arm_group_label": "Experimental Study Product", 
                "intervention_name": "Experimental Study Product", 
                "intervention_type": "Other", 
                "other_name": "Oral nutritional supplement for people with Diabetes."
            }, 
            {
                "arm_group_label": "Control Study Product", 
                "intervention_name": "Control Study Product", 
                "intervention_type": "Other", 
                "other_name": "Water beverage."
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 7, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Addison", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60101"
                    }, 
                    "name": "Biofortis Clinical Research"
                }, 
                "investigator": {
                    "last_name": "Andrea Lawless, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45249"
                    }, 
                    "name": "Radiant Research"
                }, 
                "investigator": {
                    "last_name": "Michael Noss, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of a Nutritional Supplement for People With Type 2 Diabetes (T2DM).", 
        "overall_contact": {
            "email": "kristen.deluca@abbott.com", 
            "last_name": "Kristen DeLuca, MS, RD, LD", 
            "phone": "614-624-5455"
        }, 
        "overall_contact_backup": {
            "email": "bobbie.swearengin@abbott.com", 
            "last_name": "Bobbie Swearengin, RN", 
            "phone": "614-624-7182"
        }, 
        "overall_official": {
            "affiliation": "Abbott Nutrition", 
            "last_name": "Amy Devitt-Maicher, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "An appetite questionnaire evaluating change from baseline during each study visit.", 
            "measure": "Hunger", 
            "safety_issue": "No", 
            "time_frame": "Treatment Visit 1 and Treatment Visit 2"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01850134"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "An appetite questionnaire evaluating change from baseline during each study visit.", 
                "measure": "Fullness", 
                "safety_issue": "No", 
                "time_frame": "Treatment Visit 1 and Treatment Visit 2"
            }, 
            {
                "description": "An appetite questionnaire evaluating change from baseline during each study visit.", 
                "measure": "Desire to Eat", 
                "safety_issue": "No", 
                "time_frame": "Treatment Visit 1 and Treatment Visit 2"
            }, 
            {
                "description": "An appetite questionnaire evaluating change from baseline during each study visit.", 
                "measure": "Prospective Consumption", 
                "safety_issue": "No", 
                "time_frame": "Treatment Visit 1 and Treatment Visit 2"
            }
        ], 
        "source": "Abbott Nutrition", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abbott Nutrition", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}